Trial Profile
The effect of clinical characterization of children with monosymptomatic nocturnal enuresis on the efficacy of desmopressin and alarm therapy.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 28 Feb 2023
Price :
$35
*
At a glance
- Drugs Desmopressin (Primary) ; Desmopressin (Primary)
- Indications Enuresis
- Focus Therapeutic Use
- Acronyms DRYCHILD
- 28 Feb 2023 The study has been completed in Denmark, according to European Clinical Trials Database record.
- 18 Aug 2017 Status changed from not stated to recruiting.
- 08 Aug 2017 New trial record